Meet the Proteona team at the Single Cells: Technology to Biology Symposium in Singapore
Innovative genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications
SINGAPORE, 28 January 2019 - Proteona announced that Dr Jonathan Scolnick, Chief Scientific Officer, will present at the Single Cells: Technology to Biology Symposium in Singapore on Tuesday, the 26th February, 2019. The event is part of Cell Symposia.
Dr Scolnick's talk is titled "Escape RNA sequencing: Simultaneous single-cell protein, gene expression and mutation analysis to profile the tumors". It will take place at 14:30pm at the conference venue.
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a new biomedical company based in Singapore and San Diego that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.